Keywords ABC analysis NAFLD NASH QALY biosimilar budget impact analysis chemotherapy children clinical and economic analysis cost-effectiveness analysis cost-utility analysis direct costs drug supply health technology assessment non-alcoholic fatty liver disease non-alcoholic steatohepatitis pharmacoeconomic analysis pharmacoeconomic modeling pharmacoeconomic studies pharmacoeconomics pharmacoepidemiology

Notifications

• View
• Subscribe